Naimi, B <br/><br/>
No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer.  [electronic resource] 

 -  International journal of cancer  Aug 2000 
 - 455-6 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>DNA Mutational Analysis<br/>DNA, Neoplasm--genetics<br/>Female<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Male<br/>Multiple Myeloma--epidemiology<br/>Mutation, Missense<br/>Organ Specificity<br/>Point Mutation<br/>Polymerase Chain Reaction<br/>Prostatic Neoplasms--genetics<br/>Protein-Tyrosine Kinases<br/>Receptor, Fibroblast Growth Factor, Type 3<br/>Receptors, Fibroblast Growth Factor--genetics<br/>Urinary Bladder Neoplasms--genetics<br/>Uterine Cervical Neoplasms--genetics